Papers by Heftyclassics Hefty

Diabetic Medicine, 1995
The influence of insulin binding antibodies on the pharmacokinetics of NPH insulin was studied in... more The influence of insulin binding antibodies on the pharmacokinetics of NPH insulin was studied in Type 1 diabetic patients on human insulin. Insulin-antibody binding (B,) was measured during a screening procedure in 155 Type 1 diabetic patients. In 36 patients, B, was <1.5 %, and in 38 patients B, was >10.0 %. Of these, 6 patients, group 1 (B, < 1.5 YO) and 8 patients, group 2 (B,, > 10.0 YO), respectively, subsequently participated in a pharmacokinetic study. Free insulin and the glucose infusion rate were measured using a euglycaemic clamp after subcutaneous injection of NPH insulin (0.4 U kg-'). The areas under the curve (AUC) of free insulin concentration were smaller for group 2 (p = 0.01) than for group 1 (212.2 & 22.0 vs 316.8 f 25.3 mU I-' h). The AUCs of the glucose infusion rate were also smaller for group 2 (p < 0.05) than for group 1 (2.50 f 0.32 vs 3.58 f 0.36 g kg-'). A significant negative correlation exists between the AUCs for free insulin concentration and insulin-antibody binding B, (r = 0.76, p = 0.001). The daily insulin dosage was higher in group 2 (p = 0.02) than in group 1 (0.66 f 0.03 vs 0.53 f 0.03 U kg-I). We conclude that insulin antibodies influence the pharmacokinetics of NPH human insulin. The demonstrable influence on the kinetics of free insulin and glucose utilization leads to a slight increase in daily total insulin requirements. KEY WORDS Antibody-bound insulin Free insulin Human NPH insulin Euglycaemic clamp Screening of Diabetic Patients One hundred and fifty-five Type 1 diabetic patients on human insulin for at least 6 months were screened for the presence of insulin antibodies. Mean age (SEM)

World Journal of Surgical Oncology, 2011
Background Whenever technically feasible and oncologically justified, nephron-sparing surgery is ... more Background Whenever technically feasible and oncologically justified, nephron-sparing surgery is the current standard of care for localized renal cell carcinomas (RCC). The main complications of partial nephrectomy, especially for large and centrally located tumors, are urinary leakage and parenchymal bleeding. We prospectively evaluated the pros and cons of using porcine small intestinal submucosa (SIS, Surgisis®) to close the renal defect after nephron-sparing surgery. Methods We used Surgisis® (Cook medical, Bloomington, IN, USA) to secure and compress the capsular defect after tumor resection in 123 patients submitted to 129 partial nephrectomies between August 2003 and February 2011. Results The median tumor size was 3.7 cm (range 1.1-13.0 cm). Procedures were performed with cold ischemia in 24 cases (18.2%), with warm ischemia in 46 (35.6%), and without ischemia in 59 cases (44.8%). In the total group of patients, 4 (3.1%) developed urinary fistula, and only 2 (1.6%) required ...

Diabetic Medicine, 1995
Extracting discriminative and robust features from video sequences is the first and most critical... more Extracting discriminative and robust features from video sequences is the first and most critical step in human action recognition. In this paper, instead of using handcrafted features, we automatically learn spatio-temporal motion features for action recognition. This is achieved via an evolutionary method, i.e., genetic programming (GP), which evolves the motion feature descriptor on a population of primitive 3D operators (e.g., 3D-Gabor and wavelet). In this way, the scale and shift invariant features can be effectively extracted from both color and optical flow sequences. We intend to learn data adaptive descriptors for different datasets with multiple layers, which makes fully use of the knowledge to mimic the physical structure of the human visual cortex for action recognition and simultaneously reduce the GP searching space to effectively accelerate the convergence of optimal solutions. In our evolutionary architecture, the average cross-validation classification error, which is calculated by an support-vector-machine classifier on the training set, is adopted as the evaluation criterion for the GP fitness function. After the entire evolution procedure finishes, the best-so-far solution selected by GP is regarded as the (near-)optimal action descriptor obtained. The GP-evolving feature extraction method is evaluated on four popular action datasets, namely KTH, HMDB51, UCF YouTube, and Hollywood2. Experimental results show that our method significantly outperforms other types of features, either hand-designed or machine-learned.

BJU International, 1997
Objective To compare quantitatively the reduction of their prostatic volume and necrosis assessed... more Objective To compare quantitatively the reduction of their prostatic volume and necrosis assessed using transrectal ultrasonography. volume of benign prostatic hyperplasia (BPH) achieved by laser therapy in dogs and men. Results After laser treatment, the mean reduction in the dog prostate volume was 50% and in the patients was Patients, materials and methods Twelve mongrels, with a mean prostatic volume of 33.4 mL, underwent trans-only 21%. The different impact was probably caused by anatomical differences between the human and urethral laser treatment using an Nd5YAG laser with an UltralineA fibre at 60 W power setting. The dog prostate; the human prostate consists mainly of stromal tissue and the canine prostate of glandular reduction in prostatic volume was assessed quantitatively 3 months after treatment using stereological epithelium. Conclusions The canine model gives only an approximate methods. Forty patients (mean age 70.2 years, range 51-84) with symptomatic BPH (pre-operative mean guide to the extent of tissue destruction that laser treatment can achieve in men with BPH. Furthermore, prostate volume 46.3 mL) were treated under similar operative conditions with the same laser, power and tissue differences between men may also affect the response to laser treatment. fibre system. Their urinary performance was assessed before and 6 months after treatment using urinary Keywords Benign prostatic hyperplasia, volume reduction, laser therapy, dog, human flow rates, residual volume and a symptom score, and
World Journal of Urology, 2012

International Journal of Surgical Pathology
Mixed adenoneuroendocrine carcinomas are rare and usually occur in the gastrointestinal tract. Al... more Mixed adenoneuroendocrine carcinomas are rare and usually occur in the gastrointestinal tract. Although there have been several investigations regarding their developmental mechanism, the molecular origin of these tumors remains unclear. In this article, we present an exceedingly rare case of a mixed tumor of the urinary bladder with an adenocarcinomatous and a neuroendocrine component and a concomitant urothelial carcinoma in situ (CIS). Due to this extraordinary combination of tumor components, our goal was to extensively examine the 3 tumor components with regard to a representable common origin. Therefore, a comprehensive immunohistochemical analysis and review of the literature was performed. Besides expected outcome, our examination also revealed surprising staining results. Urothelial CIS, like the adenocarcinomatous component, showed strong staining for CDX2. In addition, parts of the adenocarcinoma were positive for synaptophysin like the neuroendocrine tumor component. All...
![Research paper thumbnail of [Transurethral laser ablation of the prostate (TULAP). Initial results with 188 patients]](https://a.academia-assets.com/images/blank-paper.jpg)
Der Urologe
Laser therapy for benign prostatic hyperplasia (BPH) is now the most impressive alternative to tr... more Laser therapy for benign prostatic hyperplasia (BPH) is now the most impressive alternative to transurethral resection of the prostate (TUR-P). Transurethral laser ablation of the prostate (TULAP) is a new technique that combines non-contact and contact laser treatment of BPH. From November 1992 to August 1994, 188 patients were treated by the TULAP technique. Their median age was 70.3 (58-87) years. The mean prostatic volume determined by transrectal ultrasound, was 49.2 ml. A 6-month follow up was possible for 102 patients. The AUA 7-Symptom Score decreased from 29 points preoperatively to 6 points after 6 months. Residual urine volume decreased from 205 ml to 27 ml after 6 months. Maximum flow rate increased from 7.2 ml/s to 19.3 ml/s after 6 months. No severe complications were observed, and in particular no major bleeding or TUR syndrome. We regard the TULAP procedure as an effective treatment alternative for obstructive symptoms caused by BPH.
![Research paper thumbnail of [Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old : Morbidity, functional and oncological long-term results]](https://a.academia-assets.com/images/blank-paper.jpg)
Der Urologe
As life expectancy is increasing the incidence and therefore the number of elderly female patient... more As life expectancy is increasing the incidence and therefore the number of elderly female patients with bladder cancer is also increasing. The aim of this study was to assess long-term clinical, functional and oncological outcome in elderly women (≥70 years) who were treated by radical cystectomy and ileal neobladder reconstruction for invasive bladder cancer. A total of 121 women with clinically organ-confined invasive urothelial carcinoma underwent radical cystecomy with an orthotopic ileal neobladder in Ulm between 1995 and 2010. The clinical course, functional, pathological, and oncological outcome of these women were analyzed retrospectively and compared between patients ≥70 (n=24) and <70 years of age (n=97). All complications which occurred during the first 90 days after surgery were analyzed in detail, defined and classified according to the modified Clavien system. The overall 90 day complication rates were 66.7 % and 62.5 % for patients ≥70 and <70 years, respectivel...

Urologe, 2013
With lower rates of postoperative renal failure, diabetes and cardiovascular disease, partial nep... more With lower rates of postoperative renal failure, diabetes and cardiovascular disease, partial nephrectomy achieves longer overall survival and equally long tumor-specific survival. It is thus the current gold standard treatment for renal tumors and now also for those ≥ 4 cm in size. The main complications of nephron-sparing surgery, particularly for large and centrally located tumors, are postoperative parenchymal bleeding and urinary fistulas after opening the urinary collecting system (UCS). Between August 2003 and April 2012, 76 partial nephrectomies for tumors ≥ 4 cm in size were performed using porcine small intestinal submucosa (SIS, Surgisis®) to close the capsular, renal and in some cases, UCS defects. The median tumor size was 5.0 cm (range 4.0-13.0 cm) and the intervention was performed with warm ischemia in 25 cases (32.8 %), with cold perfusion in 16 cases (21.2 %) and without ischemia in 35 cases (46.0 %). A total of 4 patients (5.5 %) developed postoperative urinary fistulas and 4 (5.5 %) required revision surgery because of significant postoperative bleeding. There were no local infections or allergic reactions to the foreign material. Surgisis® enables a quick and technically uncomplicated closure of the renal defect after partial nephrectomy for tumors. It has the potential to further minimize postoperative bleeding and urinary fistulas and to facilitate the intervention to the extent that nephron-sparing surgery will gain broader acceptance even in patients with tumors ≥4 cm in size.

World Journal of Urology, 1996
with primary urothelial carcinoma underwent radical cystoprostatectomy and orthotopic bladder sub... more with primary urothelial carcinoma underwent radical cystoprostatectomy and orthotopic bladder substitution via the ileal neobladder. Altogether, 7.5% of the patients suffered general early complications, including thrombosis, embolism, wound infection, and pneumonia. Specific early complications directly related to formation of the neobladder and requiring surgery included ileus (4%), abscess drainage (2%), and leakage of the ileal anastomosis (0.5%). The early reoperation rate was 6.5%. Early complications that required temporary percutaneous drainage were lymphocele formation (3%) or ureteral obstruction (6%). In all, 9% of our patients required prolonged catheter drainage for leakage of the ileouretheral anastomosis. Late complications requiring reoperation were ileus (2%), abscess drainage (1%), neobladder fistula to the colon (1,5%), ureteral reimplantation because of obstruction (3.6%), and nephrectomy for hydronephrosis (1%). A transurethral incision of the ileoureteral anastomosis was necessary in 7% of cases. Continence was separately addressed by sending each patient and his home physician a detailed questionnaire: Using our criteria (no diapers, no awakenings) the night and day continence rate increased from 67% at 6 months, to 72% at 1 year, to 85% at 2 years, finally reacting 90% after 4 years. In part II of this presentation we address the question as to whether the option of orthotopic bladder replacement has any impact on the patient's and physician's decision toward earlier cystectomy. We compared our ileal neobladder cohort with a group of 137 patients that had been operated on during the same time span by the same group of surgeons. There was no negative selection with regard of the tumor stage of our patients. However, as compared with the conduit group, the neobladder cohort had a significantly improved survival rate. This phenomenon is explainable by the significantly lower number of previous transurethral resections of the bladder (TUR-Bs) performed in the neobladder group. The time span between primary diagnosis and cystectomy was 10 months in the neobladder group as compared with 18 months in the conduit patients. These data reinforce our belief that orthotopic bladder replacement using the ileal neobladder yields an
![Research paper thumbnail of [Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results]](https://a.academia-assets.com/images/blank-paper.jpg)
Der Urologe. Ausg. A, 2012
As life expectancy is increasing the incidence and therefore the number of elderly female patient... more As life expectancy is increasing the incidence and therefore the number of elderly female patients with bladder cancer is also increasing. The aim of this study was to assess long-term clinical, functional and oncological outcome in elderly women (≥70 years) who were treated by radical cystectomy and ileal neobladder reconstruction for invasive bladder cancer. A total of 121 women with clinically organ-confined invasive urothelial carcinoma underwent radical cystecomy with an orthotopic ileal neobladder in Ulm between 1995 and 2010. The clinical course, functional, pathological, and oncological outcome of these women were analyzed retrospectively and compared between patients ≥70 (n=24) and <70 years of age (n=97). All complications which occurred during the first 90 days after surgery were analyzed in detail, defined and classified according to the modified Clavien system. The overall 90 day complication rates were 66.7 % and 62.5 % for patients ≥70 and <70 years, respectivel...
Uploads
Papers by Heftyclassics Hefty